2Brain AI,Verghese C,Strube PJ.The LMA-a laryngeal mask with an Oesophageal vent.Br J Anaesth,2000,84:650-654.
3Maltby JR,Beriault MT,Watson NC,et al.LMA-Classic and LMA-ProSeal are effective alternative to endotracheal intubation for gynecologic laparoscopy.Can J Anaesth,2003,50:71-77.
1Melake MS, Yamamoto M, Yoshida K, et al. A retrospective clin- ical and angiographic study of the coiling outcome of ruptured in- tracranial aneurysms [ J ]. J Clin Neurosci, 2010, 17 ( 3 ) : 328- 333.
2Renowden SA, Benes V, Bradley M, et al. Detachable coil embo- lisation of ruptured intracranial aneurysms : a single center study, a decade experience[J]. Clin Neurol Neurosurg, 2009,111 (2): 179-188.
3Winn HR, Jane JA Sr, Taylor J, et al. Prevalence of asymptomat- ic incidental aneurysms: review of 4568 arteriograms[ J]. J Neuro- surg, 2002,96( 1 ) :43-49.
4Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneu- 17sms: A Statement for hcahhcare professionals from the Stroke Council of the American Heart Association [ J ]. Stroke, 2000, 31 ( 11 ) :2742-2750.
5Sen J, Belli A, Atbon H, et al. Triple-H therapy in the manage- ment of aneurysmal subarachnoid haemorrhage [ J ]. Lancet Neu- rol, 2003,2(10) :614-621.
6Priebe HI. Aneurysmal subarachnoid haemorrhage and the anaes- thetist[ J]. Br J Anaesth, 2007,99 ( 1 ) : 102-118.
7Cabrera LS, Santana AS, Robaina PE, et al. Paradoxical reaction to midazolam reversed with flumazenil [ J ]. J Emerg Trauma Shock, 2010,3(3) :307.
8Weinbroum AA, Geller E. Flumazenil improves cognitive and neu- romotor emergence and attenuates shivering after halothane-, en- flurane- and isoflurane-based anesthesia [ J ]. Can J Anaesth, 2001,48 ( 10 ) :963-972.
9Petroianu A, Alberti LR, de Lima DC, et al. Colonoscopic find- ings in asymptomatic people [ J ]. Arq Gastroenterol, 2009, 46(3) :173-178.
10Golshevsky J, Cormack J. Laryngeal mask airway device during coiling of unruptured cerebral aneurysms [ J ]. J Clin Neurosci, 2009,16 ( 1 ) : 104-105.
